Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia | Zendy

Katherine M. Delaney | Zendy; Ronnie Guillet | Zendy; Eva K. Pressman | Zendy; Tomas Ganz | Zendy; Elizabeta Nemeth | Zendy; Kimberly O’Brien | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia

Author(s) -

Katherine M. Delaney,

Ronnie Guillet,

Eva K. Pressman,

Tomas Ganz,

Elizabeta Nemeth,

Kimberly O’Brien

Publication year - 2021

Publication title -

journal of nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.463

H-Index - 265

eISSN - 1541-6100

pISSN - 0022-3166

DOI - 10.1093/jn/nxab093

Subject(s) - hepcidin , erythropoietin , anemia , medicine , pregnancy , endocrinology , iron deficiency anemia , hormone , gestation , biology , genetics

Maintaining adequate iron status during pregnancy is important for the mother and her developing fetus. Iron homeostasis is influenced by 3 regulatory hormones: erythropoietin (EPO), hepcidin, and erythroferrone (ERFE). To date, normative data on ERFE across pregnancy and its relations to other hormones and iron status indicators are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research